MUC1 and CREB3 are Hub Ferroptosis Suppressors for Nucleus Pulposus and Annulus Fibrosus Degeneration by Integrated Bioinformatics and Experimental Verification
Xinyu Yang,Qiaochu Li,Linbang Wang,Jiaxing Chen,Zhengxue Quan
DOI: https://doi.org/10.2147/jir.s489052
IF: 4.5
2024-11-27
Journal of Inflammation Research
Abstract:Xinyu Yang, 1, 2 Qiaochu Li, 1, 2 Linbang Wang, 3 Jiaxing Chen, 1, 2 Zhengxue Quan 1, 2 1 Department of Orthopedics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China; 2 Orthopedic Laboratory of Chongqing Medical University, Chongqing, 400016, People's Republic of China; 3 Department of Orthopedics, Peking University Third Hospital, Beijing, 100191, People's Republic of China Correspondence: Zhengxue Quan; Jiaxing Chen, Email ; Purpose: Ferroptosis is an underlying mechanism for various degenerative diseases, but its role in intervertebral disc degeneration remains elusive. This study aims to explore the key ferroptosis-related genes and its role in nucleus pulposus (NP) and annulus fibrosus (AF) degeneration. Methods: We analyzed the gene expression profiles of NP and AF from the Gene Expression Omnibus database. The ferroptosis-related differentially expressed genes (FRDEGs) in degenerated NP and AF were filtered, followed by GO and KEGG analysis. Feature FRDEGs were identified by the LASSO and SVM-RFE algorithms, and then Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA) were conducted. Immune infiltration analysis was conducted by CIBERSORT algorithm. We established drug networks via the Drug–Gene Interaction Database and competitive endogenous RNA (ceRNA) networks via miRanda, miRDB, and TargetScan database. The expression levels of the feature FRDEGs were assessed by the validation sets, single-cell RNA-seq, and experimental verification. Results: A total of 15 and 18 FRDEGs were obtained for NP and AF, respectively. GO and KEGG analysis revealed their implication in oxidative stress. Four (AKR1C1, AKR1C3, MUC1, ENPP2) and five (SCP2, ABCC1, KLF2, IDO1, CREB3) feature genes were identified for NP and AF, respectively. The GSEA and GSVA analysis showed that these feature genes were enriched in lots of biological functions, including immune response. CREB3 in degenerated AF was negatively correlated with Eosinophils via CIBERSORT algorithm. The drugs and ceRNAs targeting CREB3 and MUC1 were identified. Experimental verification and single-cell RNA-seq analysis revealed that MUC1 and CREB3 were downregulated in degenerated NP and AF, respectively. Conclusion: MUC1 and CREB3 were considered novel biomarkers for NP and AF ferroptosis, respectively. Drug and ceRNA networks were constructed for future drug development and investigation of new mechanisms of ferroptosis. Keywords: bioinformatics analysis, experimental verification, ferroptosis, nucleus pulposus, annulus fibrosus, single-cell RNA-seq Intervertebral disc degeneration (IVDD) is a prevalent age-related disease that affects a significant proportion of the adult population. 1 It is considered the main cause of lower back pain, a painful condition that imposes a substantial burden on individuals and healthcare systems worldwide. 2 The degeneration of the nucleus pulposus (NP) and annulus fibrosus (AF), the two main components of intervertebral disc, play crucial roles in the pathogenesis and progression of IVDD, with complex molecular mechanisms including inflammation and oxidative stress. 3,4 Understanding the intricate mechanisms underlying NP and AF degeneration is of great importance for the development of effective therapeutic strategies of IVDD. Researchers have recognized that reduced intervertebral disc cell numbers or cell death and extracellular matrix (ECM) degradation are pivotal processes in NP and AF degeneration. 5,6 Programmed cell death (PCD), encompassing apoptosis, autophagy, and ferroptosis, were considered significant contributors to intervertebral disc cell death and IVDD. 7–9 Among them, ferroptosis has garnered increasing attention due to its involvement in various degenerative disorders. 10–12 Ferroptosis is characterized by iron-dependent lipid peroxidation, accumulation of reactive oxygen species (ROS), and mitochondrial morphological alteration. 13 Previous research summarized that ferroptosis could be regulated by a set of genes, including drivers (promoting ferroptosis, eg nuclear receptor coactivator 4, NCOA4) and suppressors (inhibiting ferroptosis, eg ferroportin1, FPN1). 14 Recently, growing evidence has elaborated the role of ferroptosis induced by oxidative stress or inflammation in the degeneration of human NP tissues and cells, highlighting its significance in IVDD. 15 Targeting ferroptosis in NP cells has emerged as a promising therapeutic approach for IVDD treatment. 16 The upregulated methylation of glutathione peroxidase 4 ( -Abstract Truncated-
immunology